Patents by Inventor Marjorie Smith

Marjorie Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070211691
    Abstract: A method and computer program for controlling a device in a control area network having a plurality of communication paths. The method and computer program include providing one or more first application programming interfaces, each first application programming interface including one or more first sets of functions, associating a detection algorithm with at least one of the plurality of communication paths, detecting, by the detection algorithm, the device via one of the associated communication paths, and associating one of the first sets of functions with the detected device.
    Type: Application
    Filed: December 11, 2006
    Publication date: September 13, 2007
    Inventors: Ronald Barber, Joel Dick, Marjorie Smith, Mark Smith, Charles Partridge
  • Publication number: 20060067341
    Abstract: A system, method and computer program for controlling devices in a control area network that includes providing a first application programming interface containing a first set of functions in a control area network and coupling one or more functions of the first set of functions with a physical device. The control area network includes a master controller, one or more physical devices, and one or more physical communication interfaces. Coupling one or more functions of the first set of functions with a physical device.
    Type: Application
    Filed: September 9, 2005
    Publication date: March 30, 2006
    Inventors: Ronald Barber, Joel Dick, Robert Hicks, Larry Huebel, James Shillington, Marjorie Smith, Mark Smith, Michael Strong, Robert Ward
  • Patent number: 5792838
    Abstract: The invention relates to a stabilised immunoglobulin composition comprising at least one immunoglobulin together with a stabilising amount of a chelator of copper ions such as EDTA or citrate. Preferably the immunoglobulin is an antibody, for example a recombinant CDR-grafted antibody against the CDw52 antigen, most preferably CAMPATH-1H. The invention also relates to a process for enhancing the stability of an immunoglobulin which comprises subjecting the immunoglobulin to a purification procedure capable of removing copper ions therefrom. Preferably the immunoglobulin is rendered substantially free from detectable copper ions, for example on atomic absorption spectroscopy.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 11, 1998
    Assignee: Glaxo Wellcome Inc.
    Inventors: Marjorie Smith, Valentina Riveros-Rojas
  • Patent number: 5654403
    Abstract: A stabilized immunoglobulin composition comprises at least one immunoglobulin together with a stabilizing amount of a chelator of copper ions such as EDTA or citrate. Preferably the immunoglobulin is an antibody, for example, a recombinant CDR-grafted antibody. A process for enhancing the stability of an immunoglobulin comprises subjecting the immunoglobulin to a purification procedure capable of removing copper ions therefrom. Preferably, the immunoglobulin is rendered substantially free from detectable copper ions as determined, for example, by atomic absorption spectroscopy.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: August 5, 1997
    Assignee: Burroughs Wellcome Co.
    Inventors: Marjorie Smith, Valentina Riveros-Rojas
  • Patent number: D559443
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: January 8, 2008
    Inventors: Marjorie Smith, Hae-Jin Kim